Tue, October 3, 2017

by: WOPRAI

Farha Aslam Upgraded (CALM) to Buy on, Oct 3rd, 2017

by: WOPRAI

Edwin Mok Upgraded (CAMT) to Strong Buy on, Oct 3rd, 2017

by: WOPRAI

Tiffany Kanaga Downgraded (URBN) to Strong Sell on, Oct 3rd, 2017

by: WOPRAI

James Friedman Downgraded (ACN) to Hold on, Oct 3rd, 2017

by: WOPRAI

Joseph Osha Upgraded (AYI) to Hold on, Oct 3rd, 2017

by: WOPRAI

Krishna Sinha Upgraded (BAH) to Strong Buy on, Oct 3rd, 2017

Mon, October 2, 2017

by: WOPRAI

Brandon Oglenski Maintained (XPO) at Buy with Increased Target to $75 on, Oct 2nd, 2017

by: WOPRAI

Brian Nowak Maintained (YELP) at Hold with Increased Target to $40 on, Oct 2nd, 2017

by: WOPRAI

Mark May Maintained (YELP) at Strong Buy with Increased Target to $50 on, Oct 2nd, 2017

by: WOPRAI

Ravi Shanker Downgraded (CSX) to Sell on, Oct 2nd, 2017

by: WOPRAI

Greg Badishkanian Maintained (THO) at Strong Buy with Increased Target to $146 on, Oct 2nd, 2017

by: WOPRAI

Chris Olin Downgraded (STLD) to Hold on, Oct 2nd, 2017

by: WOPRAI

Matthew Harrison Upgraded (SRPT) to Buy on, Oct 2nd, 2017

by: WOPRAI

Philip Cusick Downgraded (UNIT) to Hold on, Oct 2nd, 2017

by: WOPRAI

Ravi Shanker Downgraded (UNP) to Hold on, Oct 2nd, 2017

by: WOPRAI

Benjamin Theurer Maintained (TSN) at Buy with Increased Target to $80 on, Oct 2nd, 2017

by: WOPRAI

Robert Moskow Maintained (TSN) at Hold with Increased Target to $75 on, Oct 2nd, 2017

by: WOPRAI

Andrew Boone Initiated (TTD) at Buy and Held Target at $7 on, Oct 2nd, 2017

by: WOPRAI

Nigel Coe Upgraded (SWK) to Buy on, Oct 2nd, 2017

by: WOPRAI

Christian Schwab Upgraded (STX) to Strong Buy on, Oct 2nd, 2017

by: WOPRAI

Matthew Brooklier Maintained (TRN) at Strong Buy with Increased Target to $36 on, Oct 2nd, 2017

by: WOPRAI

Prashant Rao Maintained (TRN) at Strong Buy with Increased Target to $45 on, Oct 2nd, 2017

by: WOPRAI

Brian Nowak Upgraded (TRUE) to Hold on, Oct 2nd, 2017

by: WOPRAI

James Naklicki Maintained (TRV) at Strong Buy with Decreased Target to $140 on, Oct 2nd, 2017

by: WOPRAI

Michael Lasser Downgraded (TSCO) to Hold on, Oct 2nd, 2017

by: WOPRAI

Matthew Harrison Downgraded (BLUE) to Sell on, Oct 2nd, 2017

by: WOPRAI

Michael Weinstein Maintained (BKH) at Buy with Increased Target to $77 on, Oct 2nd, 2017

by: WOPRAI

Nigel Coe Maintained (WCC) at Buy with Increased Target to $70 on, Oct 2nd, 2017

by: WOPRAI

Brandon Oglenski Maintained (WERN) at Hold with Increased Target to $32 on, Oct 2nd, 2017

by: WOPRAI

Tristan Gerra Downgraded (WDC) to Hold on, Oct 2nd, 2017

by: WOPRAI

Kaimon Chung Initiated (VIRT) at Hold and Held Target at $17 on, Oct 2nd, 2017

by: WOPRAI

Shneur Gershuni Initiated (VNOM) at Hold and Held Target at $18 on, Oct 2nd, 2017

by: WOPRAI

Nicholas Yulico Maintained (VTR) at Hold with Decreased Target to $66 on, Oct 2nd, 2017

by: WOPRAI

Terence Flynn Upgraded (ALNY) to Strong Buy on, Oct 2nd, 2017

by: WOPRAI

James Naklicki Maintained (ALL) at Strong Buy with Decreased Target to $106 on, Oct 2nd, 2017

by: WOPRAI

Manav Patnaik Maintained (BFAM) at Buy with Increased Target to $90 on, Oct 2nd, 2017

by: WOPRAI

James Naklicki Maintained (AXS) at Hold with Decreased Target to $58 on, Oct 2nd, 2017

by: WOPRAI

Brian Meredith Maintained (AXS) at Strong Sell with Decreased Target to $55 on, Oct 2nd, 2017

by: WOPRAI

David Hochstim Initiated (AXP) at Hold and Held Target at $92 on, Oct 2nd, 2017

by: WOPRAI

Rajeev Lalwani Maintained (AAL) at Hold with Increased Target to $51 on, Oct 2nd, 2017

by: WOPRAI

David George Downgraded (ZION) to Sell on, Oct 2nd, 2017

by: WOPRAI

Gregg Moskowitz Downgraded (APPN) to Hold on, Oct 2nd, 2017

Fri, September 29, 2017

by: WOPRAI

Chris Kapsch Initiated (AVY) at Hold and Held Target at $99 on, Sep 29th, 2017

by: WOPRAI

Prashant Rao Upgraded (TRN) to Strong Buy on, Sep 29th, 2017

by: WOPRAI

Bryan Goldberg Downgraded (TSQ) to Sell on, Sep 29th, 2017

by: WOPRAI

Laurent Grandet Maintained (TAP) at Hold with Decreased Target to $92 on, Sep 29th, 2017

by: WOPRAI

Robin Farley Maintained (WYNN) at Strong Buy with Increased Target to $174 on, Sep 29th, 2017

by: WOPRAI

Allison Landry Maintained (XPO) at Buy with Increased Target to $76 on, Sep 29th, 2017

Terence Flynn Upgraded (ALNY) to Strong Buy on, Oct 2nd, 2017

Terence Flynn of Goldman Sachs, Upgraded "Alnylam Pharmaceuticals, Inc." (ALNY) to Strong Buy on, Oct 2nd, 2017.

Terence has made no other calls on ALNY in the last 4 months.



There are 7 other peers that have a rating on ALNY. Out of the 7 peers that are also analyzing ALNY, 2 agree with Terence's Rating of Hold. Following are those relevant analyst calls for the last 4 months

  • Paul Matteis of "Leerink Swann" Maintained at Hold with Increased Target to $112 on, Thursday, September 21st, 2017
  • David Lebovitz of "Morgan Stanley" Maintained at Hold with Increased Target to $101 on, Thursday, September 21st, 2017


These are the ratings of the 5 analyists that currently disagree with Terence

  • Do Kim of "BMO Capital" Maintained at Buy with Increased Target to $134 on, Friday, September 22nd, 2017
  • Geoff Meacham of "Barclays" Maintained at Buy with Increased Target to $127 on, Thursday, September 21st, 2017
  • Alan Carr of "Needham" Maintained at Strong Buy with Increased Target to $125 on, Thursday, September 21st, 2017
  • Alethia Young of "Credit Suisse" Maintained at Buy with Increased Target to $123 on, Thursday, September 21st, 2017
  • Christopher Marai of "Nomura" Initiated at Sell and Held Target at $56 on, Friday, September 15th, 2017